Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease--Clinical practice recommendations.
Trenkwalder C, Chaudhuri KR, García Ruiz PJ, LeWitt P, Katzenschlager R, Sixel-Döring F, Henriksen T, Sesar Á, Poewe W; Expert Consensus Group for Use of Apomorphine in Parkinson's Disease; Baker M, Ceballos-Baumann A, Deuschl G, Drapier S, Ebersbach G, Evans A, Fernandez H, Isaacson S, van Laar T, Lees A, Lewis S, Martínez Castrillo JC, Martinez-Martin P, Odin P, O'Sullivan J, Tagaris G, Wenzel K. Trenkwalder C, et al. Among authors: martinez castrillo jc, martinez martin p. Parkinsonism Relat Disord. 2015 Sep;21(9):1023-30. doi: 10.1016/j.parkreldis.2015.06.012. Epub 2015 Jun 17. Parkinsonism Relat Disord. 2015. PMID: 26189414 Review.
Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa.
Santos García D, Martínez Castrillo JC, Puente Périz V, Seoane Urgorri A, Fernández Díez S, Benita León V, Udaeta Baldivieso B, Campolongo Perillo A, Mariscal Pérez N. Santos García D, et al. Among authors: martinez castrillo jc. Neurodegener Dis Manag. 2016 Jun;6(3):187-202. doi: 10.2217/nmt-2016-0011. Epub 2016 Apr 14. Neurodegener Dis Manag. 2016. PMID: 27075968
Dyskinesia-hyperpyrexia syndrome under continuous dopaminergic stimulation.
Acebrón Sánchez-Herrera F, García-Barragán N, Estévez-Fraga C, Martínez-Castrillo JC, López-Sendón Moreno JL. Acebrón Sánchez-Herrera F, et al. Among authors: martinez castrillo jc. Parkinsonism Relat Disord. 2017 Mar;36:103-104. doi: 10.1016/j.parkreldis.2016.12.018. Epub 2016 Dec 29. Parkinsonism Relat Disord. 2017. PMID: 28049603 No abstract available.
Simultaneous acute presentation of generalized chorea and subacute combined degeneration secondary to vitamin B12 deficiency.
Natera-Villalba E, Estévez-Fraga C, Sánchez-Herrera FA, Ruiz-Gómez F, Sanz BZ, Cánovas AA, Martínez-Castrillo JC, Corral ÍC. Natera-Villalba E, et al. Among authors: martinez castrillo jc. Parkinsonism Relat Disord. 2018 Oct;55:2-4. doi: 10.1016/j.parkreldis.2018.09.006. Epub 2018 Sep 8. Parkinsonism Relat Disord. 2018. PMID: 30220555 No abstract available.
Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.
Rascol O, Tönges L, deVries T, Jaros M, Quartel A, Jacobs D; ALLAY-LID I and ALLAY-LID II study groups. Rascol O, et al. Parkinsonism Relat Disord. 2022 Mar;96:65-73. doi: 10.1016/j.parkreldis.2022.01.022. Epub 2022 Feb 8. Parkinsonism Relat Disord. 2022. PMID: 35227940 Free article. Clinical Trial.
Efficacy and safety of high doses of safinamide in advanced Parkinson disease.
Rodríguez-Jorge F, Beltrán-Corbellini Á, Chico-García JL, Parra-Díaz P, Baena-Álvarez B, Pagonabarraga J, Pérez-Torre P, Pareés I, López-Sendón JL, Martínez-Castrillo JC, Alonso-Cánovas A. Rodríguez-Jorge F, et al. Among authors: martinez castrillo jc. Parkinsonism Relat Disord. 2022 Apr;97:73-74. doi: 10.1016/j.parkreldis.2022.03.010. Epub 2022 Mar 23. Parkinsonism Relat Disord. 2022. PMID: 35344893 No abstract available.
Response to levodopa in Parkinson's disease over time. A 4-year follow-up study.
Santos-García D, de Deus Fonticoba T, Cores Bartolomé C, Feal Painceiras MJ, García Díaz I, Íñiguez Alvarado MC, Paz JM, Jesús S, Cosgaya M, García Caldentey J, Caballol N, Legarda I, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Vela L, Escalante S, Mendoza Z, Martínez Castrillo JC, Alonso PS, Alonso Losada MG, López Ariztegui N, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos-García D, et al. Among authors: martinez castrillo jc, martinez martin p. Parkinsonism Relat Disord. 2023 Nov;116:105852. doi: 10.1016/j.parkreldis.2023.105852. Epub 2023 Oct 3. Parkinsonism Relat Disord. 2023. PMID: 37804623
194 results